| Patent application number | Description | Published |
|---|
| 20100113372 | Method For Preparing Kaempferol-3-0-Rutinoside and Composition of Skin External Application Comprising Thereof - Disclosed is a method for the preparation of kaempferol-3-O-rutinoside and a composition of a skin external application comprising kaempferol-3-O-rutinoside as an active ingredient. The method for isolating kaempferol-3-O-rutinoside through hydrolysis uses an enzyme or microbe that removes the sugar selectively from kaempferol-3-O-rutinoside glycosides in a plant extract. Disclosed also is a composition of a skin external application comprising kaempferol-3-O-rutinoside that prevents skin wrinkle. | 05-06-2010 |
| 20110002911 | METHOD FOR FERMENTING NATURAL MATERIALS WITH SALT AND FERMENTED EXTRACTS PREPARED THEREFROM - The present invention relates to a method for fermenting natural products with salt and fermented extracts prepared thereby. The method comprises: adding a predetermined amount of salt to at least one of natural products, including medicinal herbs and cereals; naturally fermenting the salted material; and extracting the fermented salted material with a solvent. Accordingly, the method can prevent the growth of various bacteria, including putrefactive bacteria, | 01-06-2011 |
| 20110052731 | MEDICINAL PLANTS EXTRACT USING PROCESSING OF HERBAL MEDICINE AND COMPOSITION OF SKIN EXTERNAL APPLICATION COMPRISING THE SAME - The present invention relates to an extract of a processed herbal medicinal plant and a composition for skin external application which contains the extract. More specifically, the composition for skin external application contains an extract of processed herbal medicinal plant, prepared through a method comprising the steps of: (a) processing an herbal medicinal plant by a process of boiling, steaming, roasting, baking or heating the medicinal plant or a combination of two or more of these processes; (b) obtaining an extract of the processed medicinal plant. The composition shows an improved antioxidant effect. | 03-03-2011 |
| 20110142972 | COSMETIC COMPOSITION CONTAINING SALT-FERMENTED EXTRACT OF NATURAL MATERIALS - The present invention relates to a cosmetic composition containing a fermented extract of natural material. More specifically, the present invention discloses a cosmetic composition that contains either a salt-fermented extract of at least one of red bean, mung bean and black bean or a salt-fermented extract of a mixture obtained by adding deep-sea water to at least one of red bean, mung bean and black bean, and thus has antioxidant and anti-aging effects. | 06-16-2011 |
| 20110223263 | ANTIOXIDANT COSMETIC COMPOSITION CONTAINING EXTRACT OF PROCESSED PEONY, POLYGONATI RHIZOMA OR LILY - The present invention relates to an antioxidant cosmetic composition, and more particularly to an antioxidant cosmetic composition containing, as an active ingredient, either an extract of at least one of peony, Polygonati rhizoma and lily, processed using a medicinal herb processing technique, or a mixture of said extract and an extract of at least one of unprocessed peony, Polygonati rhizoma and lily. | 09-15-2011 |
| 20110223265 | ANTIOXIDANT COMPOSITION CONTAINING EXTRACT OF PROCESSED CHRYSANTHEMUM INDICUM OR CITRUS UNSHIU PEEL - The present invention relates to an antioxidant cosmetic composition, and more particularly to an antioxidant cosmetic composition containing, as an active ingredient, either an extract of at least one of | 09-15-2011 |
| 20110223268 | COSMETIC COMPOSITION CONTAINING EXTRACTS OF ADENOPHORA TRIPHYLLA VAR. JAPONICA HARA, ANGELICA TENUISSIMA AND MEDICINAL HERBS - Disclosed herein is a cosmetic composition containing, as an active ingredient, a mixture of extracts of honey-roasted | 09-15-2011 |
| 20110224291 | SKIN EXTERNAL COMPOSITION FOR INHIBITING EPIDERMAL HYPERPROLIFERATION AND ALLEVIATING INFLAMMATORY SKIN DISEASES CONTAINING ORTHODIHYDROXYISOFLAVONE DERIVATIVES - Disclosed herein is a skin external composition for inhibiting epidermal hyperproliferation and alleviating inflammatory skin diseases, which contains ortho-dihydroxyisoflavone derivatives as an active ingredient. Specifically, the skin external external composition contains the ortho-dihydroxyisoflavone derivatives, 4′,6,7-trihydroxyisoflavone, 3′,4′,7-trihydroxyisoflavone or a mixture thereof, and thus increases the expression of DKK3 protein and FZD1 protein, which appropriately control Wnt signaling, thereby inhibiting epidermal hyperproliferation and alleviating inflammatory skin diseases caused by epidermal hyperproliferation. | 09-15-2011 |
